(Q45044001)

8 December 2017

miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1. (English)

1 reference

8 December 2017

0 references

1 reference

Jian Chen

1

1 reference

8 December 2017

Xingli Fu

2

1 reference

8 December 2017

Yi Wan

3

1 reference

8 December 2017

Zhimin Wang

4

1 reference

8 December 2017

Dongyi Jiang

5

1 reference

8 December 2017

Lei Shi

6

1 reference

8 December 2017

language of work or name

1 reference

19 March 2014

1 reference

8 December 2017

1 reference

8 December 2017

35

1 reference

8 December 2017

7

1 reference

8 December 2017

6293-6302

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-014-1821-4

8 December 2017

0 references

cites work

Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

21 January 2018

Brain tumour stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

MicroRNA-146a inhibits glioma development by targeting Notch1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

Stem cell division is regulated by the microRNA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

Pharmacogenomics genes show varying perceptibility to microRNA regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

MicroRNAs and pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

Real-time quantification of microRNAs by stem-loop RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

miR-125b promotes cell proliferation by directly targeting Lin28 in glioblastoma stem cells with low expression levels of miR-125b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

MicroRNA regulates human vitamin D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

miR-125b Is an adhesion-regulated microRNA that protects mesenchymal stem cells from anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

MiR-125b orchestrates cell proliferation, differentiation and migration in neural stem/progenitor cells by targeting Nestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

MicroRNA-125b is a novel negative regulator of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1821-4

Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.

21 January 2018

1 reference

12 December 2020

miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3.

1 reference

12 December 2020

PNA-based antisense oligonucleotides for micrornas inhibition in the absence of a transfection reagent

1 reference

12 December 2020

MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis.

1 reference

12 December 2020

Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.

1 reference

12 December 2020

MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf.

1 reference

12 December 2020

Annexin V staining during reperfusion detects cardiomyocytes with unique properties

1 reference

12 December 2020

p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells

1 reference

12 December 2020

10.1007/S13277-014-1821-4

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

0 references

1 reference